Showing 1,241 - 1,260 results of 1,436 for search '"Cancer staging"', query time: 0.19s Refine Results
  1. 1241

    Follow-Up Liver Stiffness Measurements after Liver Resection Influence Oncologic Outcomes of Hepatitis-B-Associated Hepatocellular Carcinoma with Liver Cirrhosis by Jung Il Lee, Hyun Woong Lee, Seung Up Kim, Sang Hoon Ahn, Kwan Sik Lee

    Published 2019-03-01
    “…A total of 184 patients that received curative surgery for HCC related to the hepatitis B virus at Barcelona Clinic Liver Cancer stage 0–A, and had a METAVIR fibrosis score of 4 were investigated. …”
    Get full text
    Article
  2. 1242

    Investigation of the Relationship between Prostate Weight and Clinical Outcomes in Retzius- Sparing Robot-Assisted Radical Prostatectomy by Selim Tas, Sahin Kilic

    Published 2023-09-01
    “…There was no difference in clinical cancer stages and The International Society of Urological Pathology (ISUP) scores between the groups. …”
    Get full text
    Article
  3. 1243

    High-dose chemoradiotherapy followed by surgery versus surgery alone in esophageal cancer: a retrospective cohort study by Smaaland Rune, Monge Odd R, Øvrebø Kjell, Hurmuzlu Meysan, Wentzel-Larsen Tore, Viste Asgaut

    Published 2010-06-01
    “…</p> <p>Conclusion</p> <p>We found no significant survival advantage in esophageal cancer stage IIA-III following preoperative high-dose CRT compared to surgery alone. …”
    Get full text
    Article
  4. 1244

    Clinicopathologic characteristics and outcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection by Abdulrahman A. Aljumah, Hadi Kuriry, Nabiha Faisal, Hamdan Alghamdi

    Published 2018-09-01
    “…HBV-associated HCC occurred at a more advanced Barcelona Clinic Liver Cancer stage. The overall median survival and treatment outcome for each modality was comparable. …”
    Get full text
    Article
  5. 1245

    Abstaining from annual health check-ups is a predictor of advanced cancer diagnosis: a retrospective cohort study by Yuki Kuwabara, Maya Fujii, Aya Kinjo, Yoneatsu Osaki

    Published 2022-02-01
    “…Conclusions: This is the first study reporting that not undergoing health check-ups is a predictor of cancer diagnosis and advanced cancer stage. Primary prevention strategies for NHI members who do not undergo health check-ups must be reassessed. …”
    Get full text
    Article
  6. 1246

    Correlation between Pre-Operative 25-Hydroxyvitamin D Levels and Poor Prognostic Factors for Papillary Thyroid Cancer by Munire Abuduwaili, Zhichao Xing, Baoying Xia, Yuan Fei, Jingqiang Zhu, Anping Su

    Published 2022-05-01
    “…After adjusting parameters such as sex, age, body mass index, and thyroid-stimulating hormone (TSH) levels, severe VDD and moderate VDD were found to be closely associated with advanced cancer stage (stage III or IV) (P = 0.018, OR = 3.02; P = 0.041, OR = 3.60, respectively). …”
    Get full text
    Article
  7. 1247

    Ways of enhancement of the surgical treatment efficacy in treatment of patients, suffering pulmonary tumors by V. V. Boyko, V. V. Kritsak, A. G. Krasnoiaruzhskyi, V. G. Groma, D. V. Minukhin, D. O. Yevtushenko

    Published 2018-12-01
    “…In the investigation 181 patients were included, suffering pulmonary cancer Stages II-III, morphologically confirmed, and with coexistent endobronchitis. …”
    Get full text
    Article
  8. 1248
  9. 1249

    Clinicopathological Features and Treatment Outcomes of Male Breast Cancer in Pakistani Population: A 10-Year Retrospective Cross-Sectional Study by Ibtissam Bin Khalid, Albash Sarwar, Hassham Bin Khalid, Barka Sajjad, Bushra Rehman, Muhammad Asad Parvaiz

    Published 2024-02-01
    “…Men with a histologically proven breast cancer, stage 0 to III disease and requiring surgical intervention were included. …”
    Get full text
    Article
  10. 1250

    The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study by Barclay, NL, Pineda Moncusí, MP, Jödicke, AM, Prieto-Alhambra, D, Raventós, B, Newby, D, Delmestri, A, Man, WY, Chen, X, Català, M

    Published 2024
    “…Delays in diagnosis are likely to have adverse consequences on cancer stage, treatment initiation, mortality rates, and years of life lost. …”
    Journal article
  11. 1251

    The Pattern of Second Primary Tumours in Postmenopausal Women with Prior Breast Cancer in Western Romania: A Retrospective, Single-Institution Study by Cristina Marinela Oprean, Larisa Maria Badau, Robert-Alexandru Han, Teodora Hoinoiu, Gabriel-Mugur Dragomir, Daciana Grujic, Tiberiu Dragomir, Alis Dema

    Published 2021-10-01
    “…The criteria for selection were based on the completeness of the documentation of the first treatment for breast cancer, stage of disease, molecular subtype, the site of origin of the second tumours and the survival data. …”
    Get full text
    Article
  12. 1252

    Factors associated with cancer survival disparities among Aboriginal and Torres Strait Islander peoples compared with other Australians: A systematic review by Paramita Dasgupta, Veronica Martinez Harris, Veronica Martinez Harris, Gail Garvey, Joanne F. Aitken, Joanne F. Aitken, Joanne F. Aitken, Joanne F. Aitken, Peter D. Baade, Peter D. Baade, Peter D. Baade

    Published 2022-09-01
    “…Studies varied widely in the covariates adjusted for including a combination of socio-demographics, cancer stage, comorbidities, and treatment. Potential contributions of these factors varied by cancer type. …”
    Get full text
    Article
  13. 1253

    Predictive accuracy of risk prediction models for recurrence, metastasis and survival for early-stage cutaneous melanoma: a systematic review by Andrew Bryant, Fiona Pearson, Luke Vale, Dawn Craig, Diarmuid Coughlan, Catherine Richmond, Tafadzwa Patience Kunonga, Robert Ellis, Fiona R Beyer, R P W Kenny, Margaret Astin, Vasileios Kontogiannis, Claire H Eastaugh, Penny Lovat

    Published 2023-09-01
    “…Objectives To identify prognostic models for melanoma survival, recurrence and metastasis among American Joint Committee on Cancer stage I and II patients postsurgery; and evaluate model performance, including overall survival (OS) prediction.Design Systematic review and narrative synthesis.Data sources Searched MEDLINE, Embase, CINAHL, Cochrane Library, Science Citation Index and grey literature sources including cancer and guideline websites from 2000 to September 2021.Eligibility criteria Included studies on risk prediction models for stage I and II melanoma in adults ≥18 years. …”
    Get full text
    Article
  14. 1254

    Adjuvant therapy with Huatan Sanjie Granules improves the prognosis of patients with primary liver cancer: a cohort study and the investigation of its mechanism of action based on... by Juhua Yuan, Abdusami Abdurahman, Ning Cui, Tengteng Hao, Jianhua Zou, Liren Liu, Yu Wu

    Published 2023-05-01
    “…In particular, the median survival time of Barcelona Clinic Liver Cancer stage C patients was 411 days in the exposure group, which was 137 days longer than that in the control group (HR, 0.59; 95% CI, 0.35–0.96; p = 0.036). …”
    Get full text
    Article
  15. 1255

    Health‐related quality of life of esophageal cancer patients in daily life after treatment: A multicenter cross‐sectional study in China by Qian Liu, Hongmei Zeng, Ruyi Xia, Gang Chen, Shuzheng Liu, Zhiyi Zhang, Yuqin Liu, Guizhou Guo, Guohui Song, Yigong Zhu, Xianghong Wu, Bingbing Song, Xianzhen Liao, Yanfang Chen, Wenqiang Wei, Wanqing Chen, Guihua Zhuang

    Published 2018-11-01
    “…Conclusions Esophageal cancer significantly impaired patients' HRQoL in daily life after treatment. Advanced cancer stages were associated with larger decrements on health state utility. …”
    Get full text
    Article
  16. 1256

    Characteristics and chronologically changing patterns of late-onset breast cancer in Korean women of age ≥ 70 years: A hospital based-registry study by Hyun-June Paik, Suk Jung Kim, Ku Sang Kim, Yongsuk Kim, Se Kyung Lee, Su Hwan Kang, Jeong Joon, Hyun Jo Youn, Korean Breast Cancer Society

    Published 2022-12-01
    “…Conclusions Based on a hospital-based registry, overall, Korean OBC had favorable biological features but showed a higher rate of TNBC and advanced cancer stages. The incidence trend of breast cancer in Korea is slowly shifting toward an older age at onset, largely due to the luminal A subtype. …”
    Get full text
    Article
  17. 1257

    Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC) by Sang-Yun Lee, Hyeong Jun Cho, Jimin Choi, Bosung Ku, Seok Whan Moon, Mi Hyoung Moon, Kyung Soo Kim, Kwanyong Hyun, Tae-Jung Kim, Yeoun Eun Sung, Yongki Hwang, Eunyoung Lee, Dong Hyuck Ahn, Joon Young Choi, Jeong Uk Lim, Chan Kwon Park, Sung Won Kim, Seung Joon Kim, In-Seong Koo, Woo Seok Jung, Sang-Hyun Lee, Chang Dong Yeo, Dong Woo Lee

    Published 2023-11-01
    “…This study proposes a multi-parameter analysis method (cancer organoid-based diagnosis reactivity prediction, CODRP) that considers the cancer stage and cancer cell growth rate, which represent the severity of cancer patients, in the sensitivity test. …”
    Get full text
    Article
  18. 1258

    Comparison of <i>BRAF</i> Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients by Maria Colombino, Carla Rozzo, Panagiotis Paliogiannis, Milena Casula, Antonella Manca, Valentina Doneddu, Maria Antonietta Fedeli, Maria Cristina Sini, Grazia Palomba, Marina Pisano, Paolo A. Ascierto, Corrado Caracò, Amelia Lissia, Antonio Cossu, Giuseppe Palmieri

    Published 2020-07-01
    “…Consecutive patients with AJCC (American Joint Committee on Cancer) stage IIIC and IV MM from Sardinia, Italy, who were referred for molecular testing, were enrolled into the study. …”
    Get full text
    Article
  19. 1259

    Characteristics of second primary breast cancer after ovarian cancer: a Korea central cancer registry retrospective study by Eun-Gyeong Lee, Jiwon Lim, Hyeong In Ha, Myong Cheol Lim, Myong Cheol Lim, Myong Cheol Lim, Yoon Jung Chang, Yoon Jung Chang, Young-Joo Won, So-Youn Jung, So-Youn Jung

    Published 2023-09-01
    “…Demographic and clinical characteristics and overall survival (OS) rates were estimated according to age, histological type, and cancer stage.ResultsAmong the 228,329 patients included, 228,148 were patients with PBC, and 181 patients had SPBC diagnosed after ovarian cancer (OC). …”
    Get full text
    Article
  20. 1260

    Attenuated miR-203b-3p is critical for ovarian cancer progression and aptamer/miR-203b-3p chimera can be explored as a therapeutic by Tao Li, Yue Li, Hina Rehmani, Jianhui Guo, Ravi Padia, Ozlem Calbay, Zuo Ding, Yunhan Jiang, Lingtao Jin, Shuang Huang

    Published 2022-07-01
    “…Here we show that miR-203b–3p is one of the miRNAs whose expression is diminished in advanced ovarian cancer (Stage III/IV). Introducing miR-203b-3p into ovarian cancer cells suppressed cell migration, in vitro invasion and peritoneal metastatic colonization. …”
    Get full text
    Article